General Motors Company (BIT:1GM)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	44,170	56,578	44,504	44,719	74,848	48,723
Market Cap Growth	-18.53%	27.13%	-0.48%	-40.25%	53.62%	4.56%
Enterprise Value	145,425	158,364	130,885	132,420	160,192	123,152
Last Close Price	47.44	51.55	32.26	30.55	49.26	32.99
PE Ratio	7.95	8.15	4.91	5.36	8.65	9.54
PS Ratio	0.28	0.31	0.29	0.31	0.67	0.49
PB Ratio	0.76	0.89	0.72	0.66	1.29	1.20
P/TBV Ratio	0.84	1.00	0.83	0.76	1.56	1.50
P/FCF Ratio	-	6.30	4.94	7.02	11.09	5.24
P/OCF Ratio	-	2.91	2.35	2.98	5.61	3.58
EV/Sales Ratio	0.90	0.88	0.84	0.90	1.43	1.23
EV/EBITDA Ratio	13.12	8.77	9.17	7.94	10.78	11.03
EV/EBIT Ratio	26.80	12.89	15.04	11.79	15.93	17.60
EV/FCF Ratio	11.75	17.63	14.53	20.80	23.73	13.25
Debt / Equity Ratio	2.00	2.00	1.80	1.60	1.68	2.24
Debt / EBITDA Ratio	8.06	6.87	7.62	6.39	6.43	7.95
Debt / FCF Ratio	9.43	14.08	12.34	17.03	14.40	9.77
Asset Turnover	0.66	0.68	0.64	0.62	0.53	0.53
Inventory Turnover	9.25	9.74	8.88	8.95	8.66	9.39
Quick Ratio	0.97	0.90	0.83	0.86	0.84	0.79
Current Ratio	1.22	1.13	1.08	1.10	1.10	1.01
Return on Equity (ROE)	6.96%	8.91%	14.00%	14.06%	17.22%	13.22%
Return on Assets (ROA)	2.27%	2.88%	2.24%	2.95%	2.98%	2.31%
Return on Capital (ROIC)	3.20%	4.10%	3.17%	4.11%	4.24%	3.44%
Return on Capital Employed (ROCE)	5.30%	6.90%	5.40%	6.90%	6.70%	5.50%
Earnings Yield	12.58%	10.26%	20.59%	20.79%	11.77%	10.78%
FCF Yield	28.03%	15.88%	20.25%	14.24%	9.02%	19.08%
Dividend Yield	0.71%	0.90%	1.01%	0.55%	-	0.94%
Payout Ratio	10.81%	8.82%	4.71%	2.59%	-	10.41%
Buyback Yield / Dilution	16.22%	17.53%	5.85%	0.95%	-1.80%	-0.21%
Total Shareholder Return	16.93%	18.43%	6.86%	1.50%	-1.80%	0.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.